Hjem › Kardiovaskulær sykdom › Kentucky
Kliniske studier for Kardiovaskulær sykdom i Kentucky
15 studier for Kardiovaskulær sykdom søker deltakere på steder i Kentucky.
Byer i Kentucky
Offisiell studietekst (engelsk)
ELEVATE-HFpEF Clinical Study
- Norton Healthcare, Louisville
Rekrutterer
Alder 40 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06678841EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Qualmedica Research - Bowling Green, Bowling Green
- The Research Group of Lexington, Lexington
- Research Integrity, LLC, Owensboro
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Research Integrity, LLC, Owensboro
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06909565Product Surveillance Registry
- Edgewood
- Louisville
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Bowling Green
- Clinical Trial Site, Lexington
- Clinical Trial Site, Versailles
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07181109A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Louisville
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07816185Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Kentucky, Lexington
- University of Louisville, Louisville
Rekrutterer
Alder 18 til 100 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06310031Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Louisville VA Medical Center, Louisville
RekruttererFase 4Frivillige helsepersonell ønskes velkommen
Alder 75 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT04262206A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Bowling Green
- Research Site, Lexington
- Research Site, Lexington
- og 4 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT07000357Cardiovascular Biorepository
- University of Kentucky, Department of Internal Medicine, Division of Cardiovascular Medicine, Lexington
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT00753974OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Graves Gilbert Clinic, Bowling Green
- Baptist Health Lexington, Lexington
- The Research Group of Lexington LLC, Lexington
RekruttererFase 3
Alder 50 til 105 · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07136012Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Kentucky, Lexington
- Norton Hospital, Louisville
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT06526195Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
- University of Louisville, Louisville
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 30 til 70 · Alle kjønn · Oppdatert 10. feb. 2026 · NCT03670524Biopsy Collection and Repository Database
- University of Kentucky, Lexington
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 3. feb. 2026 · NCT05521503Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
- University of Louisville, Louisville
RekruttererFase 1/2
Alder 20 til 85 · Alle kjønn · Oppdatert 12. des. 2024 · NCT06730828Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.